Global prevalence of diabetes-related neuropathy and vascular complications: A systematic review and meta-analysis
Study context
- Population
- People with diabetes; studies from PubMed, Embase, Scopus, Web of Science and gray literature (Google Scholar, Garuda), searched to December 10, 2025155 studies
- Outcome
- Pooled prevalences of DPN and PAD
Methodological detailsmeta-regression
- Meta-regression
Pooled result
As reported in the abstract
Pooled prevalence of diabetic peripheral neuropathy (DPN)
36 %
Pooled prevalence of peripheral artery disease (PAD)
19 %
Further pooled results
Prevalence by country development status
- DPN prevalence, developed vs developing countries (higher in developing)
- 25 % vs. 39 %
- PAD prevalence, developed vs developing countries (higher in developing)
- 10 % vs. 24 %
Chronic kidney disease (CKD) comorbidity and DPN prevalence (meta-regression)
- CKD comorbidity associated with higher DPN prevalence, β
- 0.024 (95% CI 0.004-0.042)
DPN prevalence by assessment method
%
- Combination method
- 39
- Symptom assessment
- 36
- Symptoms alone
- 30
Original publication
Global prevalence of diabetes-related neuropathy and vascular complications: A systematic review and meta-analysis. Diabetes Res Clin Pract. Published 12 January 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →